Cell Manufacturing– tag –
-
Biomanufacturing Reorients: Geopolitical Forces Drive Sourcing to Qualified, Regional Capacity, with Cellares Pioneering IDMO Smart Factories
Pharma's Almanac USA Overview Geopolitical forces are profoundly reshaping biomanufacturing procurement, driving a surge in demand for 'qualified capacity' – providers with specialized expertise and robust regulatory compliance. This shi... -
Cracking the Cost Code: Cellares’ Automated Platform Targets 75% Reduction in CAR-T Manufacturing, Pinpointing Viral Vectors as Key Driver
IntuitionLabs USA Overview A new analysis highlights viral vectors as the primary cost driver in CAR-T cell therapy manufacturing, prompting an urgent need for more efficient production. While existing closed-system platforms offer incre... -
AGC Biologics: Job Posting Reveals Broad Biomanufacturing Scope, Spanning Proteins to Gene Therapies
Myworkdayjobs.com USA Overview A recent student assistant job posting from AGC Biologics has inadvertently showcased the company's remarkably extensive Contract Development and Manufacturing Organization (CDMO) capabilities. The company ... -
Chime Biologics Unveils AI-Driven Biomanufacturing Future with New Wuhan GMP-2 Facility and 100+ Bioreactor Megafactory Vision
BioPharma APAC China Overview Chime Biologics has significantly bolstered its biopharmaceutical manufacturing capabilities with the opening of its GMP-2 facility in Wuhan, China, equipped with eight Cytiva 2,000-liter single-use Xcellere... -
APAC’s Biomanufacturing Ascent: Australia Pioneers Viral Vector Production for Gene Therapies
Industry Publication Australia Overview The Asia-Pacific (APAC) region is rapidly accelerating its specialized manufacturing capabilities for high-value modalities like viral vectors and cell therapies, moving beyond traditional API prod... -
Enzene Unveils ‘NeX’ Partnership Model to Globalize Biologics Production via Continuous Manufacturing
PharmaSource India Overview Enzene has launched 'NeX,' an end-to-end partnership model designed to establish regional biopharmaceutical manufacturing capabilities globally. Leveraging its fully connected continuous manufacturing platform... -
AGC Biologics Commits Half of New Yokohama Biomanufacturing Plant to Major Long-Term Deal
Megaproject Japan Overview AGC Biologics has secured a significant multi-million dollar, long-term commercial manufacturing contract with an undisclosed pharmaceutical firm for its new Yokohama facility, set to open in 2027. This landmar... -
Scalable Automation in Adherent-Cell Cultures Boosts Yield and Quality: Corning’s HYPERStack and CellCube Systems Key to Efficiency
BioProcess International USA Overview Automation in scaling out adherent cell cultures significantly enhances consistency, proving especially effective where labor and bioprocessing expertise are limited. Automated culture platforms impr... -
PBS Biotech Joins Organoid COMMONS with Vertical-Wheel® Bioreactor to Accelerate Industrialization and Scalability of Human Organoid Models
PR Newswire (PBS Biotech) USA Overview PBS Biotech has joined Organoid COMMONS to accelerate the industrialization and scalability of human-relevant organoid models. The company contributes its unique Vertical-Wheel® bioreactor platform ... -
FUJIFILM Biosciences Unveils Oceo Rover, the First On-Demand Automated Solution for Powdered Media and Buffer Hydration, Resolving Bioprocess Bottlenecks
Bioprocess Online (FUJIFILM Biosciences) Japan Overview FUJIFILM Biosciences has launched the Oceo Rover, the first on-demand automated solution for powdered media and buffer hydration. This innovative system integrates hydration and ste...
